Contact Information
8202 Clearvista Parkway Building 6, Suite D, Indianapolis, Indiana 46256, United States
Detailed Information
Spero Health Indianapolis
-
Services:
- State department of health
- Council on Accreditation (COA)
- Commission on Accreditation of Rehabilitation Facilities (CARF)
- Drug Enforcement Agency (DEA)
- State mental health department
- State Substance use treatment agency
- SAMHSA certification for opioid treatment program (OTP)
- Mental health services
- Suicide prevention services
- Case management service
- Housing services
- Recovery coach
- Mentoring/peer support
- Employment counseling or training
- Self-help groups
- Private for-profit organization
- Medicare
- State-financed health insurance plan other than Medicaid
- Private health insurance
- Federal military insurance (e.g., TRICARE)
- Medicaid
- Cash or self-payment
- Sign language services for the deaf and hard of hearing
- Outpatient
- Regular outpatient treatment
- Outpatient methadone/buprenorphine or naltrexone treatment
- In-network prescribing entity
- Professional interventionist/educational consultant
- Comprehensive substance use assessment
- Outreach to persons in the community
- Screening for tobacco use
- Screening for substance use
- Interim services for clients
- Complete medical history/physical exam
- Vaping permitted in designated area
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- This facility administers/prescribes medication for alcohol use disorder
- Opioids detoxification
- Alcohol Detoxification
- Benzodiazepines Detoxification
- Methamphetamines detoxification
- Cocaine Detoxification
- Medication routinely used during detoxification
- Smoking permitted in designated area
- 12-step facilitation
- Matrix Model
- Trauma-related counseling
- Cognitive behavioral therapy
- Telemedicine/telehealth therapy
- Substance use disorder counseling
- Brief intervention
- Community reinforcement plus vouchers
- Contingency management/motivational incentives
- Motivational interviewing
- Anger management
- Relapse prevention
- Female
- Male
- In-network prescribing entity
- Detoxification
- Substance use treatment
- Treatment for gambling disorder
- Treatment for other addiction disorder
- Pregnant/postpartum women
- Adult women
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Clients who have experienced sexual abuse
- Clients with co-occurring mental and substance use disorders
- Clients who have experienced trauma
- Adult men
- Veterans
- Young adults
- Clients who have experienced intimate partner violence, domestic violence
- Criminal justice (other than DUI/DWI)/Forensic clients
- Seniors or older adults
- Clients with HIV or AIDS
- Clients with co-occurring pain and substance use disorders
- Members of military families
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Buprenorphine (extended-release, injectable)
- Naltrexone (oral)
- Non-nicotine smoking/tobacco cessation
- Medications for Hepatitis C treatment
- Nicotine replacement
- Clonidine
- Buprenorphine without naloxone
- Buprenorphine with naloxone
- Medication for mental disorders
- Acamprosate (CampralĀ®)
- Naltrexone (extended-release, injectable)
- Lofexidine
- Disulfiram
- Outcome follow-up after discharge
- Naloxone and overdose education
- Aftercare/continuing care
- Discharge Planning
- Young Adults
- Adults
- Prescribes naltrexone
- Lofexidine or Clonidine detoxification
- Accepts clients using MAT but prescribed elsewhere
- Buprenorphine maintenance
- Prescribes buprenorphine
- Buprenorphine detoxification
- Relapse prevention with naltrexone
- Maintenance service with medically supervised withdrawal after stabilization
- Hepatitis education, counseling, or support
- HIV or AIDS education, counseling, or support
- Group counseling
- Individual counseling
- Substance use disorder education
- Smoking/vaping/tobacco cessation counseling
- Health education services other than HIV/AIDS or hepatitis
- Drug and alcohol oral fluid testing
- Breathalyzer or blood alcohol testing
- Testing for Hepatitis C (HCV)
- Drug or alcohol urine screening
- Testing for Hepatitis B (HBV)
- HIV testing
License/Certification/Accreditation
Ancillary Services
Recovery Support Services
Facility Operation (e.g., Private, Public)
Payment/Insurance/Funding Accepted
Language Services
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
External Opioid Medications Source
Assessment/Pre-treatment
Facility Vaping Policy
Type of Alcohol Use Disorder Treatment
Detoxification (medical withdrawal) Services
Facility Smoking Policy
Treatment Approaches
Gender Accepted
External Source of Medications Used for Alcohol Use Disorder Treatment
Type of Care
Other Services
Special Programs/Groups Offered
Opioid Medications used in Treatment
Pharmacotherapies
Transitional Services
Age Groups Accepted
Type of Opioid Treatment
Education and Counseling Services
Testing
Opening Hours
Monday
6:00 am - 10:00 pm
Tuesday
6:00 am - 10:00 pm
Wednesday
6:00 am - 10:00 pm
Thursday
6:00 am - 10:00 pm
Friday
6:00 am - 10:00 pm
Saturday
6:00 am - 10:00 pm
Sunday
6:00 am - 10:00 pm